Road to recovery: drugs used in stroke rehabilitation

References

• Stedman Medical Dictionary Williams & Wilkins, MD, USA (1995).
   Google Scholar
• Al Moutaery K, Al Deeb S, Ahmad Khan H, Tariq M. Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery 53(3), 704–711 (2003).
   PubMed Web of Science ®Google Scholar
• Long D, Young J. Dexamphetamine treatment in stroke. Quart. j Med. 96(9), 73–85 (2003).
   Google Scholar
• Methylphenidate and other drugs for treatment of hyperactive children. Med. Letters19(3), 53–55 (1977).
   Google Scholar
• Frierson RL, Wey JJ, Tabler JB. Psychostimulants for depression in the medically ill. Am. Fain. Physician 43(1), 163–170 (1991).
   Google Scholar
• Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch. Phys. Med. Rehab. 79(9), 1047–1050 (1998).
   Google Scholar
• Walker-Batson D, Curtis S, Natarajan R et al A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stmke 32 (9), 2093–2098 (2001).
   Google Scholar
• Elovic E. Use of provigil for underarousal following TBL I Head Trauma Rehab. 15(4), 1068–1071 (2000).
   Google Scholar
• Pizzuti D. Reference 03-4735-R18. Abbott Laboratories, Pharmaceutical Products Division, IL, USA, December (1996).
   Google Scholar
• Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 358(9284), 787–790 (2001).
   PubMed Web of Science ®Google Scholar
• •Excellent small randomized clinical trial utilizing levodopa for motor recovery after stroke.
   Google Scholar
• Dobkin BH, Hanlon R. Dopamine agonist treatment of antegrade amnesia from a mediobasal forebrain injury. Ann. Neural 33(3), 313–316 (1993).
   PubMed Web of Science ®Google Scholar
• Powell JH, al-Adawi S, Morgan J, Greenwood RJ. Motivational deficits after brain injury: effects of bromocriptine in 11 patients. .1. Neural. Neurosurg. Psych. 60(4), 416–412 (1996).
   Google Scholar
• Muller U, von Cramon DY. The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage. Progress in Neuro PTchopharmacol. Biol. Psych. 18(7), 1103–1120 (1994).
   Google Scholar
• Pulaski KH, Emmett L. The combined intervention of therapy and bromocriptine mesylate to improve functional performance after brain injury. Am. Occupational Ther 48(3), 263–270 (1994).
   PubMed Web of Science ®Google Scholar
• Baezner H, Oster M, Henning O, Cohen S, Hennerici MG. Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis. Cembrovascular Dis. 11(3), 235–244 (2001).
   PubMed Web of Science ®Google Scholar
• Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke (Cochrane Review). In: The Cochrane Library Issue One. John Wiley & Sons Ltd, Chichester, UK (2004).
   Google Scholar
• ••Excellent Cochrane meta-analysis on theuse of medications in aphasia.
   Google Scholar
• Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 217,855–857 (1982).
   Google Scholar
• Killian GA, Holzman PS, Davis JM eta]. Effects of psychotropic medication on selected cognitive and perceptual measures. Abnamal fisychol 93,58–70 (1984).
   Google Scholar
• Anonymous. Drugs for psychiatric disorders. Med. Letters 33,43–50 (1991).
   Google Scholar
• Anonymous. Drugs for psychiatric disorders. Med. Letters 36,89–96 (1994).
   Google Scholar
• Mysiw WJ, Sandel ME. The agitated brain injured patient. Part 2: pathophysiology and treatment. Arch. Phys. Med. Rehabil 78,213–220 (1997).
   Google Scholar
• Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia (Cochrane Review). In: The Cochrane Library Issue One. John Wiley & Sons Ltd, Chichester, UK (2004). Excellent Cochrane meta-analysis justifying a limited use of haloperidol for agitation in stroke survivors and other patients with dementia
   Google Scholar
• Seneff MG, Mathews RA. Use of haloperidol infusions to control delirium in critically ill adults. Ann. Pharmacol 29, 690–693 (1995).
   Web of Science ®Google Scholar
• Elovic EP, Lansang R, Li Y, Ricker JH. The use of atypical antipsychotics in traumatic brain injury. J. Head Trauma Rehabil. 18(2), 177–195 (2003).
   PubMed Web of Science ®Google Scholar
• Temple MJ. Use of atypical antipsychotics in the management of post-traumatic confusional states in traumatic brain injury J. Root Army Med Corps. 149(1), 54–55 (2003).
   Google Scholar
• Schreiber S, KLag E, Gross Y, Segman RII, Pick CG. Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. Int. Gun. fiychopharmacol. 13(6), 273–275 (1998).
   Google Scholar
• Yudofsky SC, Silver JM, Hales RE. Pharmacologic management of aggression in the elderly. J. Clin. 13,Tchol. 51 (Suppl. 10), 22–28 (1990).
   Google Scholar
• Anonymous. Drugs for psychiatric disorders. Med. Letters 22(19), 77–84 (1980).
   Google Scholar
• Anonymous. Drugs for psychiatric disorders. Med. Letters 25,45–52 (1983).
   Google Scholar
• Anonymous. Drugs for psychiatric disorders. Med. Letters 31,13–20 (1989).
   Google Scholar
• Anonymous. Trazodone (Desyrel): a new nontricyclic antidepressant. Med. Letters 24,47–48 (1982).
   Google Scholar
• Anonymous. Nefazodone for depression. Med. Letters 37,33–35 (1995).
   Google Scholar
• Anonymous. Paroxetine for treatment of depression. Med. Letters 35,24–25 (1993).
   Google Scholar
• Anonymous. Ruoxetine for depression. Med. Letters 30,45–47 (1988).
   Google Scholar
• Anonymous. Ruoxetine (Prozac) revisited. Med. Letters 32,83–85 (1992).
   Google Scholar
• Anonymous. Sertraline for treatment of depression. Med. Letters 34,47–48 (1992).
   Google Scholar
• Anonymous. Choice of an antidepressant. Med. Letters 35,25–26 (1993).
   Google Scholar
• Finley PR. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann. Pharmacol. 28,1359–1369 (1994).
   Web of Science ®Google Scholar
• Anonymous. Bupropion for depression. Med. Letters 31,97–98 (1989).
   Google Scholar
• Anonymous. Venlafaxine — a new antidepressant. Med. Letters 36,49–50 (1994).
   Google Scholar
• Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch. Int. Med. 156,1047–1052 (1996).
   PubMed Web of Science ®Google Scholar